Knoll Capital Management, LLC Diversified Active

CIK: 0001325083 · Show all filings

Period: Q3 2019 (← Previous) (Next →)

Filing Date: Nov 14, 2019

Total Value ($000): $109,262 (100.0% shares, 0.0% debt)

Holdings (23)

— Biohaven Pharmactl Hldg Co L 32.7%

Value ($000) $35,775 Shares 857,494 Est. Cost $27.10 Unrealized —

— Corbus Pharmaceuticals HLDGS 22.2%

Value ($000) $24,281 Shares 4,985,870 Est. Cost $4.98 Unrealized —

— Blackstone Group LP 6.8%

Value ($000) $7,473 Shares 153,000 Est. Cost $34.97 Unrealized —

— Abeona Therapeutics Inc 4.9%

Value ($000) $5,333 Shares 2,359,767 Est. Cost $4.97 Unrealized —

— Applied Therapeutics Inc 4.7%

Value ($000) $5,133 Shares 467,071 Est. Cost $8.24 Unrealized —

KRYS Krystal Biotech Inc 3.8%

Value ($000) $4,174 Shares 120,212 Est. Cost $10.08 Unrealized +343.4%

MO Altria Group Inc 3.4%

Value ($000) $3,681 Shares 90,000 Est. Cost $29.72 Unrealized -7.1%

— Eiger Biopharmaceuticals Inc 3.3%

Value ($000) $3,590 Shares 350,238 Est. Cost $10.44 Unrealized —

KBA Kraneshares TR 2.6%

Value ($000) $2,870 Shares 96,000 Est. Cost $31.89 Unrealized —

ALDX Aldeyra Therapeutics Inc 2.6%

Value ($000) $2,801 Shares 531,568 Est. Cost $8.55 Unrealized -37.1%

— Centurylink Inc 2.5%

Value ($000) $2,746 Shares 220,000 Est. Cost $12.48 Unrealized —

AVXL Anavex Life Sciences Corp 2.1%

Value ($000) $2,288 Shares 724,205 Est. Cost $3.56 Unrealized -19.0%

DD Dupont de Nemours Inc 2.0%

Value ($000) $2,139 Shares 30,000 Est. Cost $27.24 Unrealized -4.9%

DOW Dow Inc 1.3%

Value ($000) $1,430 Shares 30,000 Est. Cost $36.37 Unrealized -10.0%

ENTX Entera Bio Ltd 1.1%

Value ($000) $1,184 Shares 475,540 Est. Cost $6.29 Unrealized -53.8%

CTVA Corteva Inc 0.8%

Value ($000) $840 Shares 30,000 Est. Cost $25.02 Unrealized +6.6%

— Molecular Templates 0.7%

Value ($000) $751 Shares 113,905 Est. Cost $4.04 Unrealized —

— Soligenix Inc. 0.7%

Value ($000) $748 Shares 787,830 Est. Cost $2.11 Unrealized —

— Galmed Pharmaceuticals Ltd 0.6%

Value ($000) $696 Shares 145,694 Est. Cost $11.90 Unrealized —

— Catasys Inc 0.6%

Value ($000) $678 Shares 43,034 Est. Cost $16.93 Unrealized —

— Electrocore Inc 0.4%

Value ($000) $481 Shares 219,844 Est. Cost $16.51 Unrealized —

— Lipocine Inc New 0.1%

Value ($000) $141 Shares 50,000 Est. Cost $1.30 Unrealized —

— Vascular Biogenics Ltd 0.0%

Value ($000) $29 Shares 21,400 Est. Cost $1.31 Unrealized —

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
—	Biohaven Pharmactl Hldg Co L	857,494	$35,775	32.7%	$27.10	—	COM	G11196105
—	Corbus Pharmaceuticals HLDGS	4,985,870	$24,281	22.2%	$4.98	—	COM	21833P103
—	Blackstone Group LP	153,000	$7,473	6.8%	$34.97	—	COM UNIT LTD	09253U108
—	Abeona Therapeutics Inc	2,359,767	$5,333	4.9%	$4.97	—	COM	00289Y107
—	Applied Therapeutics Inc	467,071	$5,133	4.7%	$8.24	—	COM	03828A101
KRYS	Krystal Biotech Inc	120,212	$4,174	3.8%	$10.08	+343.4%	COM	501147102
MO	Altria Group Inc	90,000	$3,681	3.4%	$29.72	-7.1%	COM	02209S103
—	Eiger Biopharmaceuticals Inc	350,238	$3,590	3.3%	$10.44	—	COM	28249U105
KBA	Kraneshares TR	96,000	$2,870	2.6%	$31.89	—	BOSERA MSCI CH	500767405
ALDX	Aldeyra Therapeutics Inc	531,568	$2,801	2.6%	$8.55	-37.1%	COM	01438T106
—	Centurylink Inc	220,000	$2,746	2.5%	$12.48	—	COM	156700106
AVXL	Anavex Life Sciences Corp	724,205	$2,288	2.1%	$3.56	-19.0%	COM NEW	032797300
DD	Dupont de Nemours Inc	30,000	$2,139	2.0%	$27.24	-4.9%	COM	26614N102
DOW	Dow Inc	30,000	$1,430	1.3%	$36.37	-10.0%	COM	260557103
ENTX	Entera Bio Ltd	475,540	$1,184	1.1%	$6.29	-53.8%	SHS	M40527109
CTVA	Corteva Inc	30,000	$840	0.8%	$25.02	+6.6%	COM	22052L104
—	Molecular Templates	113,905	$751	0.7%	$4.04	—	COM	608550109
—	Soligenix Inc.	787,830	$748	0.7%	$2.11	—	COM	834223307
—	Galmed Pharmaceuticals Ltd	145,694	$696	0.6%	$11.90	—	SHS	M47238106
—	Catasys Inc	43,034	$678	0.6%	$16.93	—	COM PAR	149049504
—	Electrocore Inc	219,844	$481	0.4%	$16.51	—	COM	28531P103
—	Lipocine Inc New	50,000	$141	0.1%	$1.30	—	COM	53630X104
—	Vascular Biogenics Ltd	21,400	$29	0.0%	$1.31	—	COM	M96883109